Neurovigil Company

NeuroVigil is a leading neurotechnology revolutionizing EEG analysis for clinical trials, communication and space applications.

Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Moffett Field, California, United States
Founded Date: 2007-02-05
Last Funding Date: 2015-05-01
Estimated Revenue: $1M to $10M
Investors Number: 3
Industry: NeuroTech